期刊文献+

高血压患者颈动脉病变与血管活性物质相关性探讨 被引量:9

Association of Carotid Lesions with Vasoactivators in Hypertensive Patients
暂未订购
导出
摘要 为探讨高血压患者颈动脉病变与血管活性物质的关系 ,对 10 5例高血压患者行颈动脉超声检查 ,根据病变的不同情况分为正常组 (30例 )、增厚组 (30例 )、硬斑块组 (30例 )和软斑块组 (15例 ) ,对上述患者测定血清中一氧化氮、内皮素、神经肽 -Y、低密度脂蛋白及纤维蛋白原水平。结果发现 ,颈动脉软斑块组与正常组比较 ,神经肽-Y、低密度脂蛋白和纤维蛋白原生成增加 ,一氧化氮生成减少 (P <0 .0 5 )。颈动脉硬斑块组与正常组比较上述指标也有差异 (P <0 .0 5 )。提示颈动脉斑块的形成与高血压引起的内皮损伤、脂质代谢异常有明显关系。 Aim To access the relationship between carotid lesions and some vasoactivators in patients with hypertension. Methods 105 hypertensive patients were divided into four groups based on the result of carotid arterial sonography: normal group(30 cases), endothelial thickness group(30 cases), hard plaque group(30 cases) and soft plaque group(15 cases). Several vasoactivators were determined in these patients, including nitrogen monoxide(NO), endothelin(ET), neuropeptide Y(NPY), fibrinogen(FIB), low density lipoprotein(LDL) and total cholesterol(TC). Results Compared with non-plaque group,soft plaque group had higher levels of LDLC,NPY, FIB and lower levels of NO. The difference was significant(P<0.05). Hard plaque group had also different levels of above vasoactivor parameters from that of normal group (P<0.05). Conclusion There was a significant association between the formation of carotid atherosclerotic lesions and the hypertensive injury and disorders of lipids metabolism.
出处 《中国动脉硬化杂志》 CAS CSCD 2001年第2期140-142,共3页 Chinese Journal of Arteriosclerosis
关键词 高血压 颈动脉斑块 血管活性物质 颈动脉超声 Hypertension Carotid Atherosclerotic Plaque Vasoactivator Carotid Arterial Sonography
  • 相关文献

参考文献8

  • 1[1]Fourcelot L, Tranquart F, Bray JM. Ultrasound characterization and quantification of carotid atherosclerosis lesions [J]. Minerva Cardioangiol, 1999, 47(1): 15-24
  • 2[2]Hamsten A. The hemostatic system and coronary heart disease [J]. Thromb Res, 1993, 70: 31-38
  • 3[3]Heinnch J, Balleisen L, Schulte H. Fibrinogen and factor Ⅷ in the prediction of coronary risk: result from the PROCAM study in healthy men [J]. Arterioscler Thromb, 1994, 14: 54-59
  • 4[4]Ress DD, Palmer RM, Moncade S. Role of endothchum - denved nitric oxide in the regulation of blood pressure [J]. Proc Natl Acad Sa USA, 1989, 86: 3 375-378
  • 5[5]Barrett MI, Wills AI, Vane JR. Inhibition of platetet-denved mitogen release by nitric oxide (EDRF) [J]. Agents Actions, 1989, 27: 488-491
  • 6[6]Britten M, Schachinger V. The role of endothelial function for ischemic manifestations of coronary atherosclerosis [J]. Herz, 1998, 23(2): 97-105
  • 7[7]Britten MB, Zeiber AM, Schachinger V. Clinical important of coronary endothelial vasodilator dysfunction and therapeutic options [J]. J Intern Med, 1999, 245(4): 315-327
  • 8[8]Zukowska GZ, Pruszczyk P, Colton C, et al. Mitogenic Effects of neuropeptide Y inratvascular smooth muscle cell [J]. Peptides, 1993, 14: 263-268

同被引文献83

引证文献9

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部